Introduction
Leishmania are sandfly transmitted parasitic protists that are thought to chronically infect more than 120 million people world-wide, causing a spectrum of diseases in 12 million people ranging from self-healing cutaneous lesions to life-threatening visceral infections (Pigott et al., 2014) . Infection is initiated by promastigote stages which are injected into the skin during a sandfly bloodmeal, and are rapidly internalized by monocytes and macrophages, either directly or after passage through short-lived neutrophils. Unlike most other microbial pathogens that target macrophages, Leishmania are delivered directly to the mature phagolysosome compartment where they differentiate into a non-motile amastigote stage. Depending on the Leishmania species involved, amastigotes can either reside within tight-fitting, individual or large spacious communal phagolysosomes. Amastigotes can reside long term within this hydrolytic compartment and are responsible for causing both acute inflammatory infections as well as longterm chronic infections.
In contrast to most other vacuolar compartments in macrophages, the mature phagolysosome is thought to contain a variety of potential carbon sources, including sugars, amino acids and lipids generated by the constitutive degradation of internalized macromolecules, extracellular matrix and apoptotic cell debris (McConville and Naderer, 2011; Naderer et al., 2015) . However, recent studies suggest that Leishmania amastigotes may switch to a slow growing, metabolically quiescent state in this niche . This switch appears to be independent of nutrient levels and tightly linked to amastigote differentiation, and may ensure that intracellular stages do not overgrow this niche and deplete other less abundant nutrients for which they are auxotrophic, including many amino acids, purines, vitamins and heme (McConville and Naderer, 2011) .
Notwithstanding the availability of different carbon sources in the macrophage phagolysosome, Leishmania amastigotes appear to be highly dependent on sugars as a major source in vivo. This is supported by metabolomic analyses which show that amastigotes preferentially catabolize glucose (or other sugars) over amino acids in vitro (Saunders et al., 2014) . While amastigotes also use fatty acids as a carbon source, carbon skeletons derived from fatty acid b-oxidation are primarily catabolized in the TCA cycle and used to synthesize non-essential amino acids (NEAA) rather than used for gluconeogenesis or energy production (Saunders et al., 2014) . Second, Leishmania amastigotes accumulate the novel carbohydrate reserve material, mannogen (b-1,2-linked mannose oligomers), suggesting that these stages may have access to a constant supply of sugars for growth and persistence in this niche . Finally, genetic disruption of hexose uptake or catabolism results in loss of virulence. Specifically, a L. mexicana mutant lacking three facilitative hexose transporters (Dlmxgt1-3) exhibits attenuated growth in culture and in ex vivo infected macrophages (Burchmore et al., 2003; Rodríguez-Contreras and Landfear, 2006; Rodriguez-Contreras et al., 2007) , while a L. major mutant lacking a key enzyme involved in the catabolism of exogenous amino sugars leads to loss of virulence in both ex vivo infected macrophages and in highly susceptible BALB/c mice (Naderer et al., 2010; Naderer et al., 2015) .
Why Leishmania are dependent on sugars for intracellular survival remains unclear. Leishmania promastigotes and amastigotes constitutively express all of the enzymes needed to utilize amino acids and gluconeogenesis suggesting that they could, in principle, switch to using amino acids as sole carbon sources (Rosenzweig et al., 2008) . The dependence of Leishmania amastigotes on sugar/ amino-sugar catabolism could reflect stage-specific down-regulation of plasma membrane transporters involved in the uptake of NEAA, such as glutamate and aspartate, that can be catabolized in the TCA cycle and/ or the availability of preferred amino acids in the phagolysosome. Alternatively, sugar metabolism could provide an adaptive advantage in the potentially oxidative environment of the phagolysosome niche.
Previous studies on the hexose transporter deficient Dlmxgt1-3 mutant line have led to the identification of bypass or suppressor mutant lines that have partially restored growth in glucose-rich medium and infectivity in ex vivo infected macrophages (Feng et al., 2013; 2009) . Biochemical analysis indicated that these lines had bypassed the need for LmxGT1-3 by up-regulating the expression of the permease, D2/LmxGT4, which can sustain some glucose uptake when overexpressed (Feng et al., 2009 ). Here we report the characterization of a new Dlmxgt1-3 suppressor line, , that exhibits a distinct adaptive response. In contrast to the previously reported suppressor line, Dlmxgt1-3 s2 exhibits even lower rates of glucose uptake than the parental mutant, which is compensated for by enhanced capacity to catabolize glutamate and aspartate as major carbon sources. This metabolic switch leads to increased intracellular growth in macrophages but does not restore virulence in mice. We show that the switch to amino acid catabolism and increased dependency on mitochondrial metabolism, in both promastigotes and amastigotes, leads to elevated levels of reactive oxygen species (ROS) and increased sensitivity to nitric oxide (NO). These data suggest that Leishmania amastigotes can use amino acids as major carbon sources in non-activated macrophages, but are restricted to using sugars (and to a lesser extent fatty acids) as major carbon sources in the pro-inflammatory environment of tissue lesions.
Results
Identification of a novel L. mexicana glucose transporter suppressor mutant, Dlmxgt1-3
s2
As previously reported (Burchmore et al., 2003) , promastigote stages of the L. mexicana Dlmxgt1-3 mutant lacking the three hexose transporters, LmxGT1-3, grow more slowly than wild type parasites when cultivated in standard RPMI medium containing 12 mM glucose and reach a lower final density in stationary phase (Fig. 1A) . The Dlmxgt1-3 promastigotes also exhibit enhanced thermosensitivity compared to wild type parasites, and are unable to survive when cultivated at 338C in low pH medium. Under these conditions, wild type promastigotes differentiate to small, amastigote-like forms which lack an emergent flagellum, while the Dlmxgt1-3 promastigotes retain their flagellum, swell up and eventually lyse ( Fig. 1B and C) . The increased thermosensitivity of the Dlmxgt1-3 mutant is also associated with a severe defect in the capacity of promastigotes to survive in ex vivo infected macrophages. Dlmxgt1-3 promastigotes are internalized by RAW macrophages at the same rate as wild type parasites (data not shown) but are unable to proliferate within these host cells ( Fig. 2A) . The Dlmxgt1-3 line was also unable to induce lesions in highly susceptible BALB/c mice ( Fig. 2B and C) and viable parasites could not be recovered from either the site of infection (skin) or adjacent lymph nodes (Fig. 2C ). Continuous culture of the Dlmxgt1-3 mutant in rich medium can lead to the appearance of suppressor strains that overgrow the Dlmxgt1-3 parasites (Feng et al., 2009) . Using this approached we isolated a new suppressor line, termed Dlmxgt1-3 s2 , which exhibited significantly faster growth rates than Dlmxgt1-3 promastigotes in RPMI medium (Fig. 1A ). This parasite line had a smaller cell body compared to wild type parasites, but was otherwise identical morphologically (Supporting Information Fig. S1 ). In contrast to the parental mutant line, Dlmxgt1-3 s2 promastigotes differentiated normally to amastigotes when suspended in low pH medium and cultivated at 338C (Fig. 1B and C) . Dlmxgt1-3 s2 amastigotes also infected both RAW and J774 macrophages and proliferated at similar or faster rates than wild type parasites in these host cells ( Fig. 2A) . In marked contrast, the virulence of Dlmxgt1-3 s2 parasites was not restored in the murine model (Fig. 2C) . Specifically, infection with 10 8 parasites did not lead to the formation of lesions in BALB/ c mice over >6 months. While biopsy of tissues and adjacent lymph nodes indicated that some Dlmxgt1-3 s2 amastigotes can persist long term in both tissues, the parasite load was approximately 7-8 orders of magnitude lower than wild type parasites (Fig. 2B ).
The Dlmxgt1-3 s2 suppressor line does not exhibit restored glucose uptake
To investigate whether the restored growth of Dlmxgt1-3 s2 promastigotes and amastigotes in rich medium and macrophages, respectively, reflected restored hexose transport in the suppressor line, rates of glucose transport were measured in wild type and mutant promastigotes. Both Dlmxgt1-3 or Dlmxgt1-3 s2 promastigotes exhibited very low rates of hexose uptake in short term 14 C-glucoselabeling studies (Fig. 3A) . The residual rates of glucose uptake in both lines (approximately 50-fold lower than in wild type promastigotes) may reflect the activity of the low affinity hexose transporter, D2/LmxGT4 which is upregulated in the Dlmgt1-3 s2 line (Feng et al., 2009 ).
We next tested whether Dlmxgt1-3 s2 promastigotes compensate for reduced hexose up-take by increasing the activity of down-stream glycolytic enzymes. Wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 promastigotes were labeled with 13 C-U-glucose over 12 h and rates of glucose uptake and secretion of key metabolic end-products of glycolysis and glycosomal succinate fermentation were monitored by 13 C-NMR. Consistent with the short-term 14 C-glucose uptake experiments, both Dlmxgt1-3 and Dlmxgt1-3 s2 promastigotes exhibited reduced rates of 13 C-U-glucose uptake and secretion of major metabolic end-products compared to wild type parasites. Strikingly, uptake of 13 C-glucose (Fig. 3B ) and the turnover of intracellular pools of glucose 6-phosphate (Fig. 3C) were significantly lower in the Dlmxgt1-3 s2 suppressor mutant compared to the parental Dlmxgt1-3 promastigotes. Similarly, direct measurement of glycolytic flux in wild type and the two mutants lines using the Seahorse metabolic analyzer showed that rates of glycolysis in Dlmxgt1-3 and Dlmxgt1-3 s2 promastigotes were significantly lower than in wild type parasites (Fig. 3D) . Interestingly, the rates of extracellular acidification (ECAR) were slightly higher in Dlmxgt1-3 s2 promastigotes compared to Dlmxgt1-3 promastigotes (Fig. 3D ). While ECAR is generally assumed to reflect the level of glycolysis, elevated ECAR can occur due to secretion of organic acid end-products. As shown below, the suppressor line has a more active TCA cycle, which could lead to secretion of TCA derived dicarboxylic acid intermediates that are not labeled with 13 C-glucose.
To further investigate the extent to which the Dlmxgt1-3 s2 promastigotes utilize glucose, wild type and mutant lines were labeled with 13 C-U-glucose for 3 h and 13 C-enrichment of key intermediates in central carbon was assessed by GC-MS. As expected, 13 C-glucose labeling of wild type promastigotes leads to high levels of 13 C-enrichment in intermediates in glycolysis, the pentose phosphate pathway, glycosomal succinate fermentation and small oligosaccharides representative of the carbohydrate reserve material, mannogen (CHO1/CHO2) ( Fig. 3E ) (Saunders et al., 2011; . 13 C-enrichment is also observed at lower levels in intermediates in the tricarboxylic acid (TCA) cycle and interconnected amino acids, such as alanine, aspartate and glutamate. No label was detected in other NEAA (Gly, Thr, Ser) indicating that these amino acids are largely salvaged from the medium (Saunders et al., 2011; . Consistent with the global 13 C-NMR flux analysis, levels of 13 C-enrichment in intermediates in all metabolic pathways was reduced in 13 C-glucose-fed Dlmxgt1-3 and further decreased in Dlmxgt1-3 s2 promastigotes. In particular, 13 C-glucose flux into mitochondrial intermediates (citrate, malate and fumarate) as well as anaplerotically synthesized glutamate and aspartate was markedly reduced in the suppressor line (Fig. 3E) . Strikingly, steady-state levels of mannogen were restored to wild type levels in the suppressor line (Supporting Information Fig. S2 ) indicating a switch to utilization of alternative carbon sources and increased flux through gluconeogenesis. These analyses suggest that Dlmxgt1-3 s2 promastigotes are metabolically adapted to using other carbon sources in the medium, which confers a strong growth advantage under standard in vitro growth conditions and in ex vivo infected macrophages, but not in mice infections. A. RAW macrophages were infected with stationary phase wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 promastigotes for 4 h (MOI 10:1). Infected macrophages were washed to remove non-internalized parasites, and cultured at 348C (5% CO 2 ) for 5 days and parasite numbers measured by microscopy. Parasite burden is expressed as number of amastigotes/100 macrophages' (solid fill) and percent macrophages infected (striped fill). The mean and standard deviation of 3 independent replicates (with >100 macrophages counted per replicate) are presented. B. BALB/c mice were infected with wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 promastigotes (2 x 10 6 parasites in stationary growth phase). Lesion size was measured weekly. C. Tissue samples from the site of infection (skin) and lymph nodes (LN) from infected mice culled at 15 weeks were serially diluted (1/10) in RPMI medium containing 10% iFCS. Parasite load was based on highest dilution that gave viable parasites after cultivation for 10 days at 278C. n/d; not detected.
The Dlmgt s2 suppressor line exhibits enhanced catabolism of glutamate Leishmania can catabolize both fatty acids and amino acids, although only the carbon skeletons of amino acids can be used to sustain net gluconeogenesis due to the absence of a functional glycoxylate cycle in these parasites (McConville and Naderer, 2011) . To investigate whether Dlmxgt1-3 s2 promastigotes exhibit increased amino acid uptake, wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 promastigotes were suspended in completely defined medium (CDM) containing a s2 parasites exhibit reduced rates of glucose catabolism compared to wild type and parental Dlmxgt1-3 parasites. A. Wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 promastigotes were suspended in RPMI containing 14 C-glucose (1 mM) and rapidly centrifuged through an aqueous/oil interface at indicated time points. Uptake was determined by liquid scintillation counting of 14 C-label in the cell pellet. Results are presented as mean and standard deviation of triplicate analyses. B. Wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 promastigotes were suspended in completely defined medium (CDM) containing 0.5 mM 13 C-Uglucose for 24 h. Rates of 13 C-glucose (Glc) utilization and secretion of 13 C-labeled end-products (bicarbonate, HCO 3 ; acetate, OAC; and alanine, Ala) was determined by 13 C NMR analysis of the medium after 24 h. C. Wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 promastigotes were cultivated in CDM containing 13 C-U-glucose (1 mM) and changes in 13 Cenrichment in glucose-6-phosphate determined by GC-MS. D. Rates of glycolysis for wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 promastigotes was determined using the Seahorse metabolic analyzer following addition of glucose (Glc), oligomycin (OLI; inhibitor of mitochondrial ATP synthase), 2-deoxyglucose (2DG, inhibitor of glycolysis) and antimycin A/rotenone (AA/Rot, inhibitors of mitochondrial respiratory chain). E. Wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 promastigotes were metabolically labeled with 13 C-U-glucose for 3 h in CDM and fractional labeling determined for 33 intermediates in central carbon metabolism by GC-MS. Abbreviations used are as follows; G6P, glucose 6-phosphate; F6P, fructose 6-phosphate; S7P, seduheptulose 7-phosphate; Rib5P, ribulose 5-phosphate; M6P, mannose-6-phosphate; 3PG, 3-phosphoglyceric acid; Gro3P, glycerol 3-phosphate; PEP, phosphoenolpyruvate; Succ, succinate; Mal, malate; Fum, fumarate; Cit, citrate; Ala, alanine; Asp, aspartate; aKG, a-ketoglutarate; Glu, glutamate. Cbicarbonate production were increased in Dlmxgt1-3 promastigotes (approximately twofold) and even further in Dlmxgt1-3 s2 promastigotes (3.5-fold) compared to wild type promastigotes (Fig. 4A ). Detailed analysis of intracellular metabolites of different parasite lines labeled with this cocktail indicated that the increased rate of catabolism of these amino acids was not due to a global increase in amino acid uptake, with rates of amino acid turnover being generally less than in wild type parasites (Supporting Information Fig. S3 ). We have previously shown that L. mexicana promastigotes co-utilize alanine, aspartate and glutamate in the presence of glucose (Saunders et al., 2011) . To investigate whether these amino acids are preferentially utilized in the Dlmxgt1-3 s2 mutant, wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 promastigotes were metabolically labeled with 13 C-U-alanine,
13
C-U-aspartate or 13 C-Uglutamate in CDM. Consistent with previous studies, wild type parasites exhibited low rates of uptake and catabolism of alanine, aspartate and glutamate (Fig. 4B) . The minimal uptake of alanine likely reflects high secretory flux of this amino acid under conditions of high glucose utilization. C-NEAA (Ala, Asp, Glu). Parasite metabolism was quenched after 3 h and 13 C-enrichment in selected carbon cycle intermediates determined by GC-MS. Abbreviations as in Fig. 3 legend and Gro2P, glycerol 2-phosphate; Oxo, oxoproline; Gly, glycine; Ser, serine; Thr, threonine; Pro, proline; Ile, isoleucine; Leu, leucine; Lys, lysine; Phe, phenylalanine; Val, valine; Put, putrescine; Orn, ornithine; Ura, uracil; CHO1, carbohydrate 1; CHO2, carbohydrate 2; I3P, inositol 3-phosphate; Ino, myo-inositol. C. Wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 promastigotes were metabolically labeled with 13 C-Uglycerol for 30 min (light orange/ grey/blue) or 60 min (dark orange/ grey/blue) and the rate of gluconeogenesis determined from fractional labeling of glucose-6-phosphate (G6P). D. Wild type or Dlmxgt1-3 s2 promastigotes were cultivated in Glc -/NEAA --CDM with or without supplementation with specific NEAA (6 mM) or glucose (6 mM) (n 5 3, mean 6 SEM).
While alanine uptake was increased in the Dlmxgt1-3 mutant and Dlmxgt1-3 s2 suppressor line, the further catabolism of this amino acid in the TCA cycle and in gluconeogenesis was low (Fig. 4B ). In contrast, the uptake and catabolism of aspartate and glutamate was increased in Dlmxgt1-3 promastigotes and further elevated in the Dlmxgt1-3 s2 suppressor line (Fig. 4B) . Significantly, label in 13 C-U-glutamate-fed Dlmxgt1-3 and Dlmxgt1-3 s2 parasite lines was primarily shunted into TCA cycle intermediates down-stream of a-ketoglutarate, with minimal labeling of citrate, indicating high rates of cataplerotic export of malate for gluconeogenesis and/or biomass production. The increased labeling of hexose-phosphates in the 13 C-glutamate-fed Dlmxgt1-3 s2 promastigotes did not appear to reflect increased expression or activity of enzymes in the gluconeogenic pathways, as 13 C-glycerol was incorporated into glucose-6-phosphate with equal efficiency in both mutant lines (Fig. 4C ). These analyses suggest that Dlmxgt1-3 s2 promastigote stages compensate for loss of LmxGT1-3 expression by increasing glutamate/aspartate uptake and catabolism, providing carbon skeletons for gluconeogenesis and ATP synthesis via mitochondrial oxidative phosphorylation.
To determine whether glutamate and/or aspartate equally supported mitochondrial metabolism and gluconeogenesis in Dlmxgt1-3 s2 , promastigotes were cultivated in glucose-free CDM containing different nonessential amino acids (NEAA). As expected, wild type promastigotes were unable to grow in glucose free-CDM lacking NEAA (Fig. 4D) . Supplementation of this medium with glutamate, but not with aspartate, proline, or alanine alone (all at 6 mM) completely restored growth (Fig. 4D ). The inability of promastigotes to utilize aspartate or alanine as sole carbon sources in the absence of glucose may reflect exhaustion of critical pools of a-ketoacids, such as a-ketoglutarate during their transamination and with concomitant disruption of TCA cycle fluxes. Dlmxgt1-3 s2 promastigotes was also only able to utilize glutamate as sole carbon sources in the absence of glucose but exhibited elevated growth compared to wild type promastigotes in glutamate-only medium (Fig. 4D ). These data are consistent with more efficient partitioning of glutamate carbon backbones into key energy-generating pathways and/or gluconeogenesis in the suppressor line.
Dlmxgt1-3 s2 amastigotes also exhibit increased amino acid catabolism
We have previously shown that L. mexicana amastigotes enter into a slow growth, metabolically quiescent state in which overall rates of glucose uptake and catabolism are greatly reduced (Saunders et al., 2014; Kloehn et al., 2015) . However, these stages are still dependent on the catabolism of sugars for the synthesis of carbon skeletons for key amino acids, such as glutamate. To investigate whether Dlmxgt1-3 s2 amastigotes exhibit a similar hardwired metabolic response, wild type and Dlmxgt1-3 s2 promastigotes were induced to differentiate to amastigotes and then labeled with 13 C-Uglucose, 13 C-U-aspartate and 13 C-U-glutamate for 3 h (Fig. 5A ). As expected, wild type axenic amastigotes (Ama axenic ) predominantly utilized 13 C-U-glucose as major carbon source, with concomitant 13 C-enrichment in all intermediates in glycolysis, the pentose phosphate pathway, succinate fermentation ( Fig. 5A ) and mannogen (data not shown). Significant labeling of NEAA (alanine, aspartate and glutamate) was also observed in 13 C-U-glucose-fed wild type amastigotes.
C-enrichment in these amino acids was higher than in 13 C-U-aspartate and 13 C-U-glutamate-fed amastigotes consistent with de novo synthesis of these amino acids predominating over salvage (Fig. 5A) . In marked contrast, Dlmxgt1-3 s2 Ama axenic exhibited negligible levels of 13 C-U-glucose uptake or labeling of intermediates in central carbon metabolism (Fig. 5A ), confirming the lack of any compensatory mechanism for salvaging sugars in the amastigote stage of the suppressor line. On the other hand, Dlmxgt1-3 s2 amastigotes exhibited enhanced uptake of both 13 C-U-aspartate and 13 C-U-glutamate, which were catabolized in the TCA cycle (Fig. 5A ). Low levels of 13 C-enrichment in sugar phosphates were observed in Dlmxgt1-3 s2 amastigotes reflecting the short labeling time and large pool of unlabeled mannogen in these cells which is constitutively mobilized to generate unlabeled hexose-phosphates. Bone marrow derived macrophages contain high levels of glutamate and aspartate (Fig. 5C ) supporting the notion that these amino acids might be available as carbon sources for intracellular amastigotes.
To confirm that intracellular Dlmxgt1-3 s2 amastigotes are able to utilize non-sugar carbon sources in the macrophage phagolysosome, we measured levels of mannogen in these stages. Mannogen levels provide a measure of the bioenergetic state of Leishmania promastigotes and amastigotes, accumulating under conditions of hexose-phosphate excess and being depleted under conditions of hexose-phosphate limitation (Ralton et al., 2003) . As shown in Fig. 5B , intracellular Dlmxgt1-3 s2 amastigotes expressed similar levels of mannogen oligomers as wild type amastigotes. The predominance of mannogen oligomers with low degree of polymerization (dp) in wild type and Dlmxgt1-3 s2 amastigotes is indicative of high rates of turnover (Ralton et al., 2003 supplementation of the medium of infected bone marrow derived macrophages (6 mM aspartate and glutamate) resulted in a significant increase in both wild type and Dlmxgt1-3 s2 parasite burden in these host cells, particularly after seven days infection (Fig. 5D ). In contrast, addition of exogenous glutamate/aspartate did not enhance intracellular growth of Dlmxgt1-3 parasites at this time point (Fig. 5D ). These data suggest that glutamate/aspartate levels in the phagolysosome of infected macrophages are limiting for intracellular growth of both wild type and Dlmxgt1-3 s2 parasites.
Dlmgt1-3 s2 amastigotes exhibit increased sensitivity to nitrosative stress While the metabolic adaptations of Dlmxgt1-3 s2 promastigotes and amastigotes promote parasite growth in rich medium and in macrophages, these adaptations did not C-enrichment (presented as fractional labeling) of selected carbon cycle intermediates determined by GC-MS. Note different scales used for representing 13 C-enrichment in glucose versus amino acid labeling experiments. B. Analysis of mannogen levels in intracellular wild type and Dlmxgt1-3 s2 amastigotes. Mannogen was extracted from J774 macrophages that had been infected for 5 days with either wild type or Dlmxgt1-3 s2 parasites. Mannogen oligomers (with degree of polymerization [dp] of 6 to > 12 mannose residues) were detected by HPAEC with amperometric detection (nC, nanoCoulombs). Mannogen oligomers were not detected in uninfected J774 macrophages. C. Bone marrow macrophages (2x10 6 cells total) were infected with WT L. mexicana promastigotes (MOI 5:1). The macrophages were maintained for 24 h before metabolism was quenched and intracellular amino acid pools quantified by GC-MS. D. The culture media of bone marrow derived macrophages infected (MOI 5:1) with either wild type, Dlmxgt1-3, or Dlmxgt1-3 s2 promastigotes was supplemented with an additional 6 mM aspartate or glutamate. Intracellular survival (expressed as percent infected macrophage) determined after 4 and 7 days (n 5 3, 100 macrophages counted per replicate; average, 6 standard deviation; * p-value < 0.05).
restore virulence in mice. We hypothesized that the switch to increased use of amino acids by intracellular amastigotes would lead to increased dependency on mitochondrial metabolism and elevated levels of endogenous reactive oxygen species formation, which may compromise parasite viability in animal infections. To confirm that intracellular Dlmxgt1-3 s2 amastigotes are indeed dependent on active mitochondrial metabolism, bone marrow derived macrophages were infected with wild type or Dlmxgt1-3 s2 parasites in the presence or absence of 1 mM or 10 mM sodium fluoroacetate (NaFAc), a competitive inhibitor of the TCA cycle enzyme aconitase (Saunders et al., 2011) . As expected, intracellular growth of wild type parasites was only modestly affected by 1 or 10 mM NaFAc during the first four days of infection, although 10 mM NaFAc led to effective clearance of parasites by day 6 (Fig. 6A) . In contrast, growth of Dlmxgt1-3 s2 amastigotes was severely restricted in the presence of 10 mM NaFAc at day 1 and by 1 mM at day 4 (Fig. 6A) .
The increased dependence of Dlmxgt1-3 s2 parasites on mitochondrial metabolism was associated with increased basal levels of ROS, as detected by staining with DCFDA. Notably, levels of ROS in Dlmxgt1-3 s2 promastigotes was 2-fold higher than in wild type parasites and 1.5-fold higher than in the parental Dlmxgt1-3 mutant (Fig. 6B) . ROS levels increased in all parasite lines in the presence of hydrogen peroxide (data not shown) or menadione (Mittra et al., 2013) but remained higher in both the Dlmxgt1-3 and Dlmxgt1-3 s2 parasite lines (Fig. 6B ). These findings suggest that increased mitochondrial oxidative phosphorylation in the mutant lines leads to elevated levels of endogenous ROS production, contributing to the loss of virulence of both Dlmxgt1-3 and Dlmgt1-3 s2 parasite lines in mice.
Recent studies have shown that Leishmania amastigotes are exposed to sub-lethal concentrations of nitric oxide in inflammatory lesions (M€ uller et al., 2013) . NO is known to be a potent inhibitor of multiple enzymes in the mitochondrial TCA cycle, which may explain why Leishmania amastigotes normally depend primarily on hexose metabolism for growth in vivo, and enter the slow growth metabolically quiescent state . To investigate whether Dlmxgt1-3 s2 Ama axenic are more susceptible to NO than wild type parasites, both lines were cultivated in the presence of different concentrations of NaNO 2 (which is converted to NO under acidic conditions (Alspaugh and Granger, 1991) ) and amastigote viability measured by FACS analysis of eFluor-stained cells. While wild type amastigotes were relatively resistant to 2 mM NaNO 2 , Dlmxgt1-3 s2 amastigotes rapidly lost viability at this concentration (Fig. 6C) . Wild type amastigotes were resistant to NaNO 2 regardless of whether they were cultivated under glucose-replete or glucose-limiting conditions, reflecting the limited capacity of non-adapted wild type amastigotes to switch to catabolizing amino acids in the TCA cycle. Dlmxgt1-3 s2 amastigotes were partially protected from NO toxicity by addition of 12 mM glucose, supporting the notion that toxicity is due to elevated mitochondrial respiration in the suppressor line. To confirm that NO does indeed inhibit mitochondrial respiration in the Dlmxgt1-3 s2 amastigotes, wild type and Dlmxgt1-3 s2 amastigotes were labeled with 13 C-U-glutamate or 13 C-U-fatty acids in the presence or absence of NaNO 2 . In both cases, NaNO 2 -treatment led to a marked decrease in the level of 13 C-enrichment in all TCA cycle intermediates (Fig. 6D) . Interestingly, NaNO 2 treatment also led to decreased uptake of glutamate which could reflect the impact of decreased mitochondrial ATP synthesis on cellular levels of ATP and ion transport fluxes in amastigotes. Finally, inhibition of mitochondrial metabolism was associated with an increase in ROS in NaNO 2 -treated Ama axenic (Fig. 6E ).
To more directly test whether host cell derived NO or ROS contributes to the severe-loss of virulence phenotype of Dlmxgt1-3 s2 parasites in mice, infected bone marrow derived macrophages were stimulated with either lipopolysaccharide (LPS) alone or in combination with interferon gamma (IFNg) (Fig. 6F ). These treatments activate NO and ROS synthesis in macrophages and resulted in partial restriction of growth of wild type parasites (Fig. 6F ). In contrast, activation of macrophages with LPS or LPS/INFg resulted in almost complete clearance of Dlmxgt1-3 s2 parasites. Compensatory up-regulation of amino acid catabolism in Dlmxgt1-3 s2 amastigotes may therefore lead to increased vulnerability to endogenous and exogenous reactive oxygen/nitrogen species, accounting for the loss of virulence phenotype of the suppressor strain in mice.
Discussion
We have identified a novel suppressor line of L. mexicana Dlmxgt1-3 in which the defect in glucose uptake is by-passed by increased catabolism of NEAA. This suppressor line was subsequently used to investigate the relationship between amastigote metabolism and capacity to survive in the phagolysosome compartment of ex vivo infected macrophages and in infected tissues. Unexpectedly, we show that while the Dlmxgt1-3 s2 line can grow in non-activated macrophages, this line is highly attenuated in activated macrophages and exhibits a severe loss of virulence in mice. These data suggest that the macrophage phagolysosome contains sufficient amino acids to sustain amastigote growth, but that utilization of respiratory carbon sources increases the sensitivity of amastigotes to host microbicidal processes s2 amastigotes are dependent on a functional TCA cycle and susceptible to nitric oxide. A. Bone marrow derived macrophages infected (MOI 5:1) with either wild type or Dlmxgt1-3 s2 amastigotes, were treated with 0, 1 or 10 mg ml 21 sodium fluoroacetate (NaFAc) and intracellular survival, expressed as percent infected macrophage, determined after 1, 4 and 6 days (representative experiment; n 5 4, 100 macrophages counted per replicate, average, 6 standard deviation). B. Levels of reactive oxygen species (ROS) in wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 promastigotes. Promastigotes were suspended in glucose-free RPMI supplemented with 10% iFCS for 2.5 h at 278C prior to the addition of 2.5 mM menadione (MEN) to increase mitochondrial metabolism or mitochondrial ROS production, respectively. Parasites were labeled with H2DCFDA (30 min, 278C) to detect ROS and fluorescence normalised to unlabeled parasites (representative experiment; n 5 3; average, 6 standard deviation; * p-value < 0.07, **pvalue < 0.05, *** p-value < 0.005). C. Wild type and Dlmxgt1-3 s2 Ama axenic were suspended in glucose-free RPMI with 20% iFCS (pH 4.5) containing 0-2 mM sodium nitrite with or without glucose supplementation, and incubated at 358C overnight. Amastigote viability was determined after eFluor staining and FACS analysis and normalization to untreated controls. D. Wild type and Dlmxgt1-3 s2 Ama axenic were cultured in CDM containing 1 mM sodium nitrite and either 13 C-U-glutamate or mixed 13 C-U-free fatty acids. Parasite metabolism was quenched after 3 h and the 13 C-enrichment (presented as fractional labeling) of selected carbon cycle intermediates was determined by GC-MS. E. Wild type and Dlmxgt1-3 s2 Ama axenic were cultured in RPMI supplemented with 20% iFCS (pH 4.5) containing varying concentrations of sodium nitrite (0 to 6 mM) for 2 h. Parasites were labeled with H2DCFDA (30 min, 33-348C) to detect ROS and fluorescence normalized to unlabeled parasites (representative experiment; n 5 3; average, 6 standard deviation; * p-value < 0.005, ** p-value < 0.0005). F. Bone marrow derived macrophages infected (MOI 5:1) with either wild type, Dlmxgt1-3 or Dlmxgt1-3 s2 promastigotes, were stimulated with lipopolysaccharide (LPS) or LPS and interferon gamma (LPS/IFNg) and intracellular survival (expressed as percent infected macrophage) determined after 4 and 7 days (representative experiment; n 5 3, 100 macrophages counted per replicate; average, 6 standard deviation).
such as ROS and reactive nitrogen species. These findings are consistent with previous studies showing that Leishmania amastigotes preferentially utilize sugars as carbon source and normally exhibit very low rates of amino acid utilization. These metabolic adaptations are part of a coordinated metabolic quiescence, or stringent response, which likely represents a critical adaption to life in the macrophage phagolysosome.
The Dlmxgt1-3 s2 suppressor line was isolated after selection of Dlmxgt1-3 promastigotes for faster growth in rich medium and subsequent clonal isolation. Detailed 13 C-labeling studies suggested that the faster growth of these promastigotes in standard rich medium was not due to restoration of glucose uptake, but rather to increased catabolism of NEAA. This phenotype was particularly evident in Dlmxgt1-3 s2 amastigotes which showed negligible rates of 13 C-U-glucose utilization, but increased rates of 13 C-U-glutamate and 13 C-U-aspartate catabolism. We have previously shown that wild type amastigotes also display increased rates of fatty acid boxidation compared to promastigotes (Saunders et al., 2014) . Dlmxgt1-3 s2 amastigotes also catabolized 13 C-Ufatty acid, although the rate of utilization was considerably less than for 13 C-amino acids. The suppressor line was also hypersensitive to the TCA cycle inhibitor, sodium fluoroacetate, and exhibited high basal levels of ROS, both consistent with increased dependence on mitochondrial metabolism. As summarized in Fig. 7 , this switch to increased amino acid and mitochondrial metabolism is likely to be essential for ATP synthesis and supply of carbon skeletons for gluconeogenesis. The precise molecular basis for increased catabolism of NEAA in Dlmxgt1-3 s2 promastigotes and amastigotes remains undefined. While it is possible that expression of plasma membrane amino acid transporters is increased in the suppressor strain, we did not observe increased uptake of NEAA or essential amino acids. It is therefore likely that the increased uptake of specific NEAA (Glu, Asp, Ala) is driven by increased catabolism and depletion of intracellular pools of these amino acids. Interestingly, while it is commonly assumed that Leishmania preferentially utilize proline as an alternative carbon source under glucose limiting conditions, neither wild type nor mutant parasite lines exhibited appreciable rates of proline uptake and catabolism (Supporting Information Fig. S3 ) or capacity to survive on this amino acid as sole carbon source in CDM. In principal, Dlmxgt1-3 s2 parasites could also acquire amino acids via increased lysosomal degradation of extracellular proteins. However, labeling studies on wild type and Dlmxgt1-3 s2 amastigotes with 13 C-algal proteins did not lead to significant 13 C-enrichment in intracellular metabolites (data not shown) indicating that amino acid uptake via surface transporters is the major route of acquisition. Similarly, both Dlmxgt1-3 and Dlmxgt1-3 s2 lines exhibited similar rates of gluconeogenesis when provided with 13 C-Uglycerol indicating that the final steps in this pathway are not up-regulated in the suppressor mutant. It is likely that the Dlmxgt1-3 s2 parasites have undergone multiple genetic changes since the generation of the original mutant. Specifically, the parental Dlmxgt1-3 line used in this study, already exhibited significant levels of glucose uptake compared to the original Dlmxgt1-3 (Burchmore et al., 2003) which may reflect increased expression of the low affinity transporter, LmxGT4 (Feng et al., 2009) . Interestingly, the Fig. 7 . Schematic summary of central carbon metabolism of wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 amastigotes. The Dlmxgt1-3 mutant line partially adapts to loss of LmxGT1-3 by increasing expression of the plasma membrane (PM) transporter, LmxGT4, as well as increased uptake of NEAA. The Dlmxgt1-3 s2 line exhibits a more robust adaptation to glucose deprivation with increased metabolism of NEAA (particularly glutamate) in the mitochondria (orange compartment) and gluconeogenesis in glycosomes (green compartment).
suppressor line exhibited lower rates of glucose uptake than the parental line, which may reflect loss of extrachromosomal element carrying LmxGT4 and/or increased flux through gluconeogenesis driven by changes in mitochondrial metabolism. Further studies will be needed to define the potential contribution of changes in gene dosage (amplification/loss), gene mutations or post-transcriptional mechanisms in driving these metabolic adaptations.
While the Dlmxgt1-3 parasites grow slowly in ex vivo infected macrophages and are eventually cleared, Dlmxgt1-3 s2 amastigotes grow at a similar or faster rate than wild type amastigotes in a variety of non-activated macrophage lines (J7741.A, RAW, murine bone marrow derived macrophages). This intracellular phenotype suggests that levels of NEAA in the phagolysosome of nonactivated macrophages are sufficient to sustain elevated rates of amastigote replication. Interestingly, supplementation of the growth medium of infected macrophages with additional glutamate/aspartate (6 mM each) stimulated the intracellular growth of both wild type and the suppressor line parasites. Thus intracellular amastigote group may be partially constrained by the availability of NEAA in the phagolysosome, although it is also possible that exogenous NEAA may directly or indirectly induce other changes in macrophage metabolism that benefit amastigote survival and proliferation. In contrast to the situation in cultured macrophages, we show for the first time that neither the Dlmxgt1-3 or Dlmxgt1-3 s2 lines induced lesions in BALB/c mice.
, but not Dlmxgt1-3 parasites were recovered from the site of injection and in proximal lymph nodes, indicating that the metabolic adaptations observed in the latter line may confer a slight advantage over the parental line. Independent infection experiments with several different clones of Dlmxgt1-3 in one of our laboratories (S. M. Landfear unpubl. data) confirmed the highly attenuated virulence phenotype of this strain, although small lesions were observed when BALB/c mice were injected in the footpad. These subtle differences may reflect cross-laboratory differences in the strains and/or the site of injection (tail versus footpad) used. Regardless, the highly attenuated virulence of Dlmxgt1-3 s2 in mice contrasted dramatically with the prolific intracellular growth of this line in ex vivo infected macrophages. There are a number of possible reasons for why the metabolic switch in the Dlmxgt1-3 s2 line may not lead to effective rescue of amastigote growth in mice compared to ex vivo infected macrophages. First, the phagolysosomes of macrophages in inflammatory lesions may contain lower levels of NEAA needed to sustain the growth and viability of this parasite lines, compared to macrophages cultured in rich medium. This possibility is supported by the finding that addition of exogenous NEAA to infected macrophages increased parasite growth. However, as noted above, L. mexicana amastigotes can also scavenge amino acids from the proteolytic breakdown of host proteins delivered to the lysosomes and are therefore not necessarily dependent on amino acids levels in the phagolysosome (Besteiro et al., 2007) . A second possibility is that Dlmxgt1-3 s2 amastigotes are more sensitive than wild type amastigotes to increased levels of ROS and/or NO in the lesion microenvironment (M€ uller et al., 2013) . Consistent with this possibility we show that axenic Dlmxgt1-3 s2 amastigotes are highly sensitive to NO and that intracellular Dlmxgt1-3 s2 amastigotes are effectively cleared by LPS or LPS/IFNg activated macrophages. Mitochondrial enzymes containing iron-sulphur clusters in the TCA cycle and respiratory chain complexes are highly vulnerable to inactivation by ROS and nitrosylation and exposure of Dlmxgt1-3 s2 amastigotes to NO leads to complete inhibition of amino acid catabolism. The increased dependency of Dlmxgt1-3 s2 amastigotes on amino acid catabolism and mitochondrial respiration may therefore increase the sensitivity of this line to sublethal production of NO in infected tissues (M€ uller et al., 2013) and constrain proliferation. Unexpectedly, ectopic expression of individual LmGT transporters (LmGT2-GFP and LmGT3-GFP) in the suppressor line did not protect this line from being cleared in LPS-activated macrophages (unpublished data). The failure to restore intracellular growth in activated macrophages could reflect partial restoration of hexose uptake in these complemented lines (Vince et al., 2011) . Alternatively, complex metabolic changes in the suppressor line may have led to amino acids being the preferred carbon source under a wide range of growth conditions. While our results suggest that a switch from glycolysis to increased dependence on mitochondrial respiration is strongly detrimental for Leishmania pathogenesis, other pathways associated with catabolism of non-sugar carbon sources may still be important in intracellular stages. Specifically, we have previously shown that L. major amastigotes are dependent on expression of the gluconeogenic enzyme, fructose-1,6-bisphosphatase (FBPase) for growth in macrophages and infectivity in mice (Naderer et al., 2006) . FBPase catalyzes the last step in gluconeogenesis and could be involved in maintaining steady-state hexose-phosphate levels, either through the conversion of carbon skeletons derived from amino acids to sugar phosphates or by regulating the flux of hexose-phosphates in upper glycolysis. In support of the latter possibility, we have recently shown that intracellular Toxoplasma gondii tachyzoites are dependent on expression of FBPase while using glucose as major carbon source to sustain high glycolytic flux (Blume et al., 2015) .
Amastigote differentiation is associated with induction of the stringent metabolic response, whereby amastigotes strongly repress their utilization of both sugars and amino acids, minimize overflow metabolism (i.e. secretion of partially oxidized end-products) and primarily utilize the TCA cycle for anabolic reactions, such as synthesis of NEAA (Saunders et al., 2014) . Our findings suggest that induction of the stringent metabolic response may have a number of functions. Specifically, the slow growth (12 day doubling time ) and low metabolic requirements of this stage would minimize the risk of overgrowing this intracellular niche and reduce the need to use carbon sources other than sugars. Entry into this state would also minimize mitochondrial metabolism in intracellular amastigote stages thereby reducing the vulnerability of this stages to macrophage NO and ROS production. A similar response is induced in amastigotes cultured under nutrient rich conditions (Saunders et al., 2014) suggesting that this response is both hardwired and has a strong adaptive advantage to intracellular amastigotes.
These studies suggest that Leishmania amastigotes have limited capacity to develop resistance to inhibitors of hexose uptake and catabolism in the glycolytic pathway, as metabolic adaptations that lead to increased utilization of other carbon sources and mitochondrial metabolism will increase their sensitivity to host microbicidal processes. Paradoxically, the dependence of Leishmania amastigotes on sugars as their major carbon source, and down-regulation of NEAA uptake, means that these stages are dependent on anapleurotic mitochondrial reactions involved NEAA biosynthesis. Indeed a number of studies have shown that inhibitors of mitochondrial metabolism have potent anti-leishmania activity (Fidalgo and Gille, 2011; Ortiz et al., 2016; Saunders et al., 2014) . These studies suggest that Leishmania amastigote metabolism is highly constrained in vivo, which offers new opportunities for drug development.
Experimental procedures
Parasite strains and growth conditions Leishmania mexicana wild type (wild type) (MNYC/BZ/62/ M379), Dlmxgt1-3 and Dlmxgt1-3 s2 promastigotes were cultured in RPMI 1640 medium (Sigma) supplemented with 10% heat inactivated foetal calf serum (iFCS, GibcoBRL) at 278C. Parasites were passaged twice weekly (1/100 and 1/ 1000 dilutions) into fresh media to maintain log phase growth. Parasite proliferation was assessed using a haemocytometer. Stationary phase promastigotes were induced to differentiate to Ama axenic by acidification of the conditioned media to pH 5.5 with HCl, and supplementation with an additional 10% iFCS (20% iFCS final) and subsequent cultivation at 338C for 5 days. For amino acid growth dependency experiments, promastigotes were suspended in glucose-free completely defined medium (Glc-free CDM) lacking NEAA, with or without supplementation with individual amino acids (6 mM). To assess the susceptibility of Ama axenic to NO, amastigotes were resuspended in glucose-free RPMI, 20% iFCS (pH 4.5, 2 3 10 7 cell ml 21 ) supplemented with glucose (0, 6, 13 mM) and sodium nitrite (0, 0.5, 1, 2 mM) (Alspaugh and Granger, 1991) . For microscopy, parasites were incubated in 4% paraformaldehyde (in PBS) for 10 min and then added to poly-L-lysine treated coverslips. Cells were visualised by DIC microscopy using the Axioplan 2 imaging microscope equipped with AttoArc 2, HBO 100 Arc Lamp Control (Zeiss).
Parasite viability
Leishmania mexicana wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 amastigotes were washed once with PBS and then incubated in propidium iodide (0.2 mg ml 21 in PBS) for 10 min. The parasites were pelleted (15,000 3 g, 30 min) then washed a further two times with PBS before being applied to coverslips and visualized by fluorescence microscopy (488 nm excitation). Microscopy was performed on the Axioplan 2 imaging microscope equipped with AttoArc 2, HBO 100 Arc Lamp Control (Zeiss). Images were collected using the Axiovision software. Alternatively, parasite viability was assessed by FACS analysis after Ama axenic were washed twice with PBS, then stained with the fixable viability dye, eFluor 520 (eBioscience, 65-0867, 5 3 10 6 cell total in 1 ml 1xPBS with 1 ml dye, 30 min, 2-88C). Parasites were washed, fixed (4% PFA, 500 ml, 30 min), washed and then resuspended in PBS (5 3 10 6 cell/500 ml) for FAC analysis. Flow cytometry results were acquired on a FACSort (BD) and data analysed with the FloJo software package.
Glucose uptake assay
Aliquots L. mexicana wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 mid log phase promastigotes (6 3 10 7 cells total) were washed twice in PBS with intermediate centrifugation (30 s, 14,000 3 g). The cell pellets were immediately suspended in 200 ll of either RPMI medium (pH 7.4) containing 0.2 mM glucose. An aliquot of the cell suspension (50 ll) was added to PCR tube and the uptake assay initiated by the addition of 50 ll of RPMI medium, prewarmed to 278C, containing 14 C-U-glucose (308 mCi/mmol, 10 lCi/assay). The cell suspension (100 ml) was layered over an oil cushion (dibutyl phthalate:mineral oil, 9:1 v/v, 50 ll) at 30, 45 and 60 s, and centrifuged (30 s, 14,000 3 g) to pellet labeled cells. The upper phase was washed twice with PBS to remove excess radiolabel and the oil-phase was then removed and the cell pellet resuspended in 0.5% SDS (250 ll). After sonication, the lysate (200 ll) was mixed with scintillation fluid (2 ml) and radioactivity determined by scintillation counting.
Stable isotope labeling experiments
Parasite lines were labeled with different 13 C-labeled carbon sources as described in (Saunders et al., 2011; . Briefly, promastigotes (in mid log phase) were washed and resuspended in glucose-free RPMI medium and aliquoted Molecular basis for Leishmania sugar addiction 155 into ten 15 ml screw cap tubes (4 3 10 7 cells per tube, one tube for each time point) and incubated at 278C. Labeling was initiated by addition of 0.8 mM 13 C-U-glucose and parasites harvested at indicated time points by rapid chilling and centrifugation (Saunders et al., 2011) . For all other labeling experiments, promastigotes (mid-log phase) or Ama axenic were resuspended in completely defined media (CDM, 2 3 10 7 cell ml
21
) containing various 13 C-labeled carbon sources. The composition of CDM, based on (Merlen et al., 1999; Saunders et al., 2011; , contained glucose (6 mM), alanine (1.9 mM), arginine (0.4 mM), glycine (3.1 mM), histidine (0.04 mM), isoleucine (0.045 mM), leucine (0.61 mM), lysine (0.55 mM), methionine (0.13 mM), phenylalanine (0.18 mM), proline (0.26 mM), serine (0.76 mM), threonine (0.34 mM), tyrosine (0.033 mM), valine (1.1 mM) and tryptophan (0.15 mM), vitamins, heme and 0.5% bovine serum albumin (BSA) containing bound fatty acids. For the labeling studies, naturally labeled carbon sources were replaced with the following 
Metabolite extraction and GC-MS analysis
Metabolically quenched cells were pelleted, washed three times with chilled PBS and extracted in chloroform:methanol:water (1:3:1 v/v, 250 ml, containing 1 nmol scyllo-inositol internal standard) at 608C for 15 min with periodic mixing. Insoluble material was pelleted by centrifugation (16,100 3 g, 5 min, 08C) and the supernatant was adjusted to chloroform:methanol:water (1:3:3 v/v) by the addition of H 2 O. After vortex mixing and phase separation by centrifugation (16,000 3 g, 5 min), the upper polar phase was transferred to GC vial inserts and dried in vacuo at 558C. Polar metabolites were methoximated (methoxyamine HCl, Supelco, 20 mg ml 21 in pyridine, 20 ml overnight incubation) and derivitised (BSTFA 1TMCS, 99:1, Supelco, 20 ml, 1-2 h) prior to GC-MS analysis (Saunders et al., 2011; . Metabolite identification was performed in Chemstation (Agilent) and referencing authentic standards. Fractional labelling and corrected mass isotopomer distributions (MID) were performed using in house DExSI software.
Macrophage infection
Bone marrow derived macrophages were harvested from Balb/c mice (tibia and femur) and suspended RPMI media supplemented with 15% iFCS, 20% L cell media, penicillin (100 U ml 21 ) and streptomycin (100 mg ml
21
) at 378C with 5% CO 2 on TC plates. The following day, differentiating (but not adherent) macrophages were transferred to petri dishes and incubated at 378C with 5% CO 2 and maintained for 5-7 days before being used. RAW macrophages were cultured in RPMI supplemented with 10% iFCS and penicillin (100 U ml
) and streptomycin (100 mg ml
) at 378C with 5% CO 2 . Cells were passaged 2-3 times weekly by scraping adherent cells into fresh media and diluting a further fivefold. Macrophages were maintained for no more than 10 passages. For imaging, macrophages were suspended in fresh RPMI 1640 supplemented with 10% iFCS (and 20% L cell media for primary macrophages), penicillin (100 U ml
) and streptomycin (100 mg ml 21 ), aliquoted into 24-well plates containing 10 mm glass cover slips (2-5 3 10 5 macrophages ml 21 , 0.5 ml per well) and allowed to adhere overnight (at 378C with 5% CO 2 ). The following day, the macrophage monolayers were overlaid with stationary phase promastigotes or Ama axenic (multitude of infection [MOI] 5:1 or 10:1). The cultures were incubated at 338C in 5% CO 2 for 4 h before non-adherent parasites were removed by washing the monolayers twice with PBS. For some experiments, the macrophage culture media was supplemented with additional aspartate/glutamate (6 mM, each), lipopolysaccharaide (LPS, 10 ng ml
) and/or interferon gamma (IFNg, 20 ng ml 21 ). The cultures were maintained at 338C with 5% CO 2 for up to 7 days. Coverslips were removed at specified time points for microscopy. To enumerate levels of infection the monolayers were washed in PBS (three times), fixed in methanol (48C, 10 min) or 4% paraformaldehyde (10 min) mounted in Hoechst containing Mowiol 4-88 or Fluoromont (eBioscience). The percent infected cells and the number of parasites per cell were quantitated by fluorescence microscopy. Parasite index was determined by multiplying the number of amastigotes per macrophage by the percent of macrophage infected. Average and standard deviation were calculated from (at least) three independent replicates. All microscopy was performed on the Axioplan 2 imaging microscope equipped with AttoArc 2, HBO 100 Arc Lamp Control (Zeiss). Images were collected using the AxioVision software. To quantify amino acid abundance in infected and uninfected host cells, bone marrow derived macrophages were plated into a 6-well plate (5 ml RPMI supplemented with 10% iFCS, 2 3 10 6 cell total) and incubated 378C overnight. Macrophages were infected with L. mexicana wild type promastigotes (MOI 5:1) for 24 h, then rapidly washed with ice-cold PBS to quench metabolism. Adherent macrophages were extracted in ice-cold methanol (1.2 ml), prior to removal of residual cell material with a cell scaper and extraction of the cell pellet in chloroform:methanol:water (1:3:1 v/v). Polar metabolites were analysed by GC-MS as described above.
NMR analysis of carbon source uptake and metabolite secretion
Wild type, Dlmxgt1-3 and Dlmxgt1-3 s2 parasites were labeled for 24 h, and the cell-free culture supernatant (540 ml) gently premixed with 5 mM D6-DSS in D 2 O (60 ml, containing 0.2% w/v NaN 3 ), 21.4 mM 13 C-U-glycerol in D 2 O (5 ml, containing 0.2% w/v NaN 3 ) and 21.4 mM imidazole in D 2 O (5 ml, containing 0.2% w/v NaN 3 ), prior to analysis by NMR.
13
C-spectra at 200 MHz were obtained using an 800 MHz Bruker-Biospin Avance fitted with a cryoprobe (Saunders et al., 2011) .
